Nanomedicine strategies show promise for targeting pancreatic ductal adenocarcinoma
Photo by Buddha Elemental 3D / Unsplash
Key Takeaway
Interpret nanomedicine for PDAC as preclinical; clinical translation remains limited.
This narrative review summarizes current nanomedicine strategies under investigation for pancreatic ductal adenocarcinoma (PDAC). The authors discuss several categories of nanocarriers and therapeutic agents, including polymeric nanoparticles, small-molecule inhibitors, siRNA, and immunomodulatory agents. The review covers mechanisms such as enhanced permeability and retention effect, tumor microenvironment modulation, and targeted drug delivery.
Key findings are qualitative, as the review does not report pooled effect sizes or meta-analytic data. The authors emphasize that most evidence comes from preclinical models, with few nanomedicine platforms having advanced to clinical trials in PDAC. They note that barriers such as dense stroma, poor vascularization, and drug resistance remain significant challenges.
The review acknowledges limitations in the current literature, including a lack of head-to-head comparisons and limited data on long-term outcomes. The authors call for more rigorous preclinical-to-clinical translation and combination strategies to overcome the desmoplastic tumor microenvironment.
Practice relevance is indirect at this stage. Clinicians should interpret these findings as exploratory; no nanomedicine-based therapy for PDAC is currently approved or standard of care based on this review. The field is evolving, and future clinical trials will determine whether these approaches improve patient outcomes.
More on Pancreatic Ductal Adenocarcinoma
Narrative review on KMT2C alterations in gastrointestinal cancers and therapeutic implications
Genetic changes in gut cancers may open new treatment doors for patients
This narrative review synthesizes evidence on KMT2C alterations across gastrointestinal malignancies. It links KMT2C dysfunction to transcri…
A review of genetic changes in gastrointestinal cancers suggests new ways to treat tumors by targeting specific DNA repair weaknesses.
Case report and literature review on IgG4-related disease misdiagnosed as pancreatic cancer in a 70-year-old male
A 70-year-old man avoided unnecessary surgery after doctors found a treatable autoimmune condition
This case report and literature review examines a 70-year-old male patient with IgG4-related autoimmune pancreatitis initially suspected as …
A 70-year-old man with a pancreatic mass was found to have a treatable autoimmune disease, sparing him from unnecessary surgery.
Robot-assisted distal pancreatectomy reduces blood loss and conversions but increases operative time and cost
Robot Surgery Matches Laparoscopic for Pancreas Cancer Outcomes
This systematic review and meta-analysis of 15790 patients undergoing distal pancreatectomy found that robot-assisted distal pancreatectomy …
New data shows robot-assisted pancreas surgery matches standard laparoscopic methods in safety and cancer control, while cutting blood loss …
RNK08954 shows unconfirmed responses in KRASG12D-mutant NSCLC and PDAC in Phase Ia trial
New drug shows promise for KRASG12D lung and pancreatic cancers
This phase Ia trial evaluated RNK08954 in 36 patients with KRASG12D-mutant non-small cell lung cancer or pancreatic ductal adenocarcinoma.
An early trial of RNK08954 shrank tumors in 58% of lung cancer patients with a specific KRAS mutation.
View Original Abstract ↓
Pancreatic ductal adenocarcinoma (PDAC) remains one of the most lethal malignancies, characterized by a dense desmoplastic stroma and a profoundly immunosuppressive tumor microenvironment (TME). The TME plays a major role in tumor progression, metastasis, and resistance to conventional therapies through a network of dysregulated signaling pathways, including KRAS, PI3K/AKT/mTOR, Raf/MAPK/ERK, TGF-β, NF-κB, Notch and Hedgehog. Moreover, cellular components such as cancer-associated fibroblasts (CAFs), tumor-associated macrophages (TAMs), and regulatory T cells (Tregs) drive immune evasion and therapeutic resistance via cytokine signaling axes, including IL-6/STAT3 and CXCL12/CXCR4. Recent advances in nanomedicine have introduced polymeric nanoparticles as promising delivery vehicles for targeted disruption of these aberrant pathways. Polymeric nanoparticles are engineered to enhance bioavailability, tissue penetration, and selective delivery, co-deliver small-molecule inhibitors, siRNA, or immunomodulatory agents directly to the TME. This approach offers a strategy to overcome biological barriers, reprogram the stroma, and sensitize tumors to immunotherapy and chemotherapy. This review comprehensively examines the signaling mechanisms of PDAC in the TME, discusses current therapeutic strategies targeting these pathways, highlights challenges, including resistance and adverse effects, and explores future directions to optimize pancreatic cancer treatment by modulating this key signaling axis with nanomedicine.
Intrawound tobramycin plus vancomycin did not reduce deep infection risk compared with vancomycin alone in high-risk tibial fractures
Adding Antibiotics to Bone Surgery Didn't Lower Infection Risk
Related in Infectious Disease
Triple antibiotic paste shows stronger antimicrobial performance than calcium hydroxide for persistent endodontic infections
Triple antibiotic paste beats calcium hydroxide for killing stubborn tooth infections
This systematic review with exploratory meta-analysis synthesized twelve studies on intracanal medicaments for persistent endodontic infecti…
Triple antibiotic paste showed stronger power to kill bacteria than calcium hydroxide, but results varied widely across different studies.
Microbial arsenic transformations influence methane oxidation, denitrification, and carbon fixation in high-arsenic environments
Microbes in arsenic-rich soil may change how much greenhouse gas the planet releases
This narrative review examines microbial transformations of arsenic in naturally high-arsenic environments. The authors synthesize evidence …
Microbes in arsenic-rich environments might alter greenhouse gas emissions. This review explains how these tiny organisms link arsenic chang…
One in six blood donors in Cameroon carries Plasmodium infection, meta-analysis finds
1 in 6 blood donors in Cameroon carries malaria parasite
A systematic review and meta-analysis of 18 studies (~12,500 donations) found a 16.6% pooled prevalence of Plasmodium spp. in Cameroonian bl…
A review of 18 studies finds 16.6% of blood donations in Cameroon contain Plasmodium, the malaria parasite.
Pooled cytomegalovirus retinitis prevalence is 3% among people with HIV in sub-Saharan Africa
Cytomegalovirus retinitis risk varies across sub-Saharan Africa regions
This systematic review and meta-analysis synthesized data from 1931 people living with HIV in sub-Saharan Africa. The pooled prevalence of c…
A meta-analysis found that cytomegalovirus retinitis prevalence in people living with HIV ranges from less than 1% to 7% depending on the re…
From Other Specialties
Pre-existing mental health issues significantly raise risks for preterm birth and low birth weight in women
Women with prior mental health issues face higher risks of preterm birth and low birth weight
A comprehensive meta-analysis of 33 studies reveals that women with pre-existing mental health problems face higher odds of adverse pregnanc…
A review of 33 studies shows women with pre-existing mental health problems have higher risks of preterm birth and low birth weight compared…
Practice-derived framework prioritizes usability and recruitment for multinational eHealth pilots
Four years of testing reveals top priorities for managing digital health pilots across Europe
This guideline synthesizes expert consensus from 23 experts across four European large-scale pilots, ranking 45 best practices across six op…
Testing a management framework for digital health pilots across Europe identified usability and active recruitment as top priorities for suc…
Non-pharmacological interventions in adult ICU patients did not improve health-related quality of life in this network meta-analysis
Non-drug ICU care shows promise but needs more proof to help patients
This network meta-analysis evaluated non-pharmacological interventions for adult ICU patients. The analysis included 2,654 patients and comp…
Non-drug treatments in the ICU may improve quality of life, but results were not statistically significant and need more research.
NINJ1 targeting shows potential for multiple sclerosis and other neurological conditions but faces significant knowledge gaps
NINJ1 targeting shows promise for multiple sclerosis and other brain injuries
This narrative review examines NINJ1 targeting as a therapeutic strategy for multiple sclerosis, ischemic stroke, traumatic brain injury, sp…
A review suggests NINJ1 targeting could help treat multiple sclerosis, stroke, and other brain injuries, though more research is needed.